|
|
||||||||
1 Departments of Medicine and Radiology, University of Minnesota Health Sciences, Minneapolis, Minnesota 55455; and 2 Centre de Génétique Moléculaire et Cellulaire, Centre National de la Recherche Scientifique Lyon I, 69622 Villeurbanne Cedex, France
| |
ABSTRACT |
|---|
|
|
|---|
This study examined high-energy phosphates (HEP) and
mitochondrial ATPase protein expression in hearts in which myocardial infarction resulted in either compensated left ventricular remodeling (LVR) or congestive heart failure (CHF). The response of HEP (measured via 31P magnetic resonance spectroscopy) to a modest
increase in the cardiac work state produced by dobutamine-dopamine
infusion and pacing (if needed) was examined in 17 pigs after left
circumflex coronary artery ligation (9 with LVR and 8 with CHF) and
compared with 7 normal pigs. In hearts with LVR, the baseline
phosphocreatine (PCr)-to-ATP ratio decreased, and calculated ADP
increased; these changes were most severe in hearts with CHF. HEP
levels did not change in normal or LVR hearts during
dobutamine-dopamine infusion. However, in hearts with CHF, the
PCr-to-ATP ratio decreased further, and free ADP increased. The
mitochondrial protein levels of the F0F1-ATPase
subunits were normal in hearts with compensated LVR. However, in
failing hearts, the
-subunit decreased by 36%, the
-subunit
decreased by 16%, the oligomycin sensitivity-conferring protein
subunit decreased by 40%, and the initiation factor 1 subunit
decreased by 41%. Thus in failing hearts, reductions in mitochondrial F0F1-ATPase protein expression
are associated with increased myocardial free ADP.
myocardial infarct; catecholamine; creatine kinase; phosphocreatine
| |
INTRODUCTION |
|---|
|
|
|---|
THE FINAL REACTION
of the sequence that links carbon substrate utilization to oxidative
ATP synthesis is the mitochondrial ATPase (mtATPase) ATP
synthase. This enzyme catalyzes the phosphorylation of ADP to
form ATP. Using a porcine model of postinfarction left ventricular
remodeling (LVR), we previously observed (22) that the
protein levels of mitochondrial adenine translocator and
F1-ATPase were decreased in animals that developed overt
congestive heart failure (CHF). On the basis of this previous finding,
in the present study, we hypothesized that the decreased expression of
mtATPase would require an increase in the cytosolic free-ADP level to
drive mitochondrial ATP synthesis. To examine this hypothesis, we
measured myocardial high-energy phosphates (HEP) with 31P
magnetic resonance spectroscopy (MRS) in swine in which occlusion of
the left circumflex coronary artery (LCx) had resulted in either compensated LVR or CHF. Measurements were obtained during basal conditions and with modest increases in cardiac work that are known not
to produce HEP changes in normal hearts (4, 33). To
determine whether oxygen insufficiency might contribute to HEP changes
in failing hearts, myocardial deoxymyoglobin (Mb-
) was assessed
using 1H MRS. Mitochondrial protein levels of the
F0F1-ATPase subunits were examined by Western blotting.
| |
METHODS |
|---|
|
|
|---|
All experimental procedures were performed in accordance with the animal use guidelines of the University of Minnesota, and the experimental protocol was approved by the University of Minnesota Research Animal Resources Committee. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1985).
Infarct production by coronary ligation. Details of the animal model of postinfarction LVR were as described previously (20, 37). In brief, Young Yorkshire swine (age 45 days; weight ~10 kg) were anesthetized with pentobarbital sodium (30 mg/kg iv), intubated, and ventilated with a respirator and supplemental oxygen. Arterial blood gases were maintained within the physiological range by adjusting the respiratory settings and the oxygen flow. A left thoracotomy was performed, and 0.5 cm of the proximal LCx was dissected free and completely occluded with a ligature. The animals were then observed in the open-chest state for 60 min. When ventricular fibrillation occurred, electrical defibrillation was performed immediately. This procedure was usually successful. The chest was then closed; if the heart was dilated, the pericardium was left open. The animals were given standard postoperative care including analgesia until they ate normally and were active. LCx occlusion was performed in 41 pigs; of these, 4 pigs died suddenly during the first 24 h after LCx ligation surgery. Studies were performed ~6 wk after the LCx occlusion. Among the 37 pigs, 8 developed CHF as evidenced by cyanosis or ascites. These 8 animals formed the CHF group. Of the remaining 29 pigs, 9 with LCx ligation formed the LVR group. The remaining 20 pigs with compensated LVR underwent experiment protocols for other studies and therefore were not included in this study.
Surgical preparation.
Before surgery, 17 animals with LVR and 7 size-matched normal animals
were anesthetized with
-chloralose (100 mg/kg then 20 mg · kg
1 · h
1 iv),
intubated, and ventilated with a respirator and supplemental oxygen.
Arterial blood gases were maintained within the physiological range by
adjusting the respiratory settings and oxygen flow. A heparin-filled
polyvinyl chloride catheter (3.0 mm OD) was introduced into the right
femoral artery and advanced into the ascending aorta. A sternotomy was
performed and the heart was suspended in a pericardial cradle. A second
heparin-filled catheter was introduced into the left ventricle through
the apical dimple and secured with a purse-string suture. A similar
catheter was inserted into the left atrium through the atrial
appendage. A bipolar pacing electrode was sutured onto the right atrial
appendage. A 25-mm-diameter NMR surface coil was sutured onto the left
ventricular (LV) anterior wall; the infarct region was avoided. The
pericardial cradle was then released, and the heart was allowed to
assume its normal position in the chest. The surface coil leads were
connected to a balanced and tuned external circuit. The animals were
then placed in a Lucite cradle and positioned within the magnet.
Spatially localized 31P NMR spectroscopic technique.
Spatially localized 31P NMR spectroscopy was performed
using adiabatic plane rotation pulses for phase modulation (RAPP) in image-selected in vivo spectroscopy (ISIS) (11, 24, 33). Detailed experiments documenting the voxel profiles and volumes and the
spatial resolution attained by this method have been published previously (11, 24, 33). In this application of the
RAPP-ISIS technique, signal origin was first restricted to an 18 × 18-mm two-dimensional column perpendicular to the LV wall and
further localized in three well-resolved and five partially resolved
layers along the column and hence across the LV wall. Localization
along the column was based on magnetic field strength generated at the center of the surface coil (B1); the phase encoding
employed a nine-term Fourier series window as previously described
(33). Complete transmural data sets were obtained
in 10-min time blocks using a repetition time of 6-7 s, which
allows full relaxation for ATP and Pi and ~90%
relaxation of the phosphocreatine (PCr) resonance. Whole wall spectra
were obtained with the ISIS, which defined a column that was 2.3 × 2.3 cm2 and perpendicular to the heart wall. NMR data
acquisition was gated to the cardiac and respiratory cycles by using
the cardiac cycle as the master clock to drive both the respirator and
the spectrometer as previously described (24). The surface
coil was constructed of a single-turn copper wire 28 mm in diameter with each side of the coil leads soldered to a 33-pF capacitor. Calibration was facilitated by including a polyethylene capillary filled with 15 µl of 3 M phosphonoacetic acid within the inner diameter of the coil. The ratio of PCr to ATP was calculated for each
spectrum. The integral value of the basal Pi (for most of the hearts, this value was zero) was subtracted from the Pi
values acquired during subsequent experimental conditions to obtain
Pi values. Pi data are presented as
Pi/PCr. All resonance intensities were quantified using
integration routines provided by SISCO software.
Calculation of myocardial-free ADP level. The myocardial- free ADP levels were calculated from the creatine kinase (CK) equilibrium expression (17) using an equilibrium constant (Keq) of 1.66 × 109 and a cytosolic pH of 7.1: [ADP] = ([ATP] [CRfree])/([PCr] [H+] Keq), where square brackets indicate concentrations. PCr and ATP values were obtained from the spectra calibrated by the biopsy-measured ATP levels. Free creatine was calculated by subtracting the PCr values from the biopsy-obtained measurements of total creatine.
1H NMR spectroscopic technique.
We have recently reported the 1H NMR methods in detail
elsewhere (6, 20). In brief, radio frequency transmission
and signal detection were performed with the dually tuned
28-mm-diameter surface coil. A single-pulse collection sequence with a
frequency-selective Gauss excitation pulse (1 ms) was used to
selectively excite the N-
proton signal of proximal histidine in
deoxymyoglobin (Mb-
) resonance. This provided sufficient water
suppression because of the large chemical-shift difference between
water and Mb-
(>14 kHz), and other techniques such as the Cornell
High-Energy Synchrotron Source [CHESS (10)] and an
inversion-recovery pulse did not significantly improve water
suppression. The NMR signal was optimized by adjusting the radio
frequency pulse power using the water signal as a reference. A short
repetition time (TR) of 25 ms was used owing to the short T1 of Mb-
.
Each spectrum was acquired in 5 min (10,000 free induction decays).
Although the short T1 of Mb-
and the fast acquisition prevented
gating to the cardiac cycle, the signal loss due to motion was
negligible because of the inherently broad line width of the Mb-
peak.
Hemodynamic measurements. Aortic and LV pressures were measured using Spectromed TNF-R pressure transducers positioned at midchest level. All data were recorded on an eight-channel Coulbourne R14-28 direct-writing recorder.
Myocardial blood flow measurements.
Myocardial blood flow (
m) was measured using
15-µm-diameter radionuclide-labeled microspheres as previously
described (3, 20, 33). Microspheres labeled with four
different radioisotopes (51Cr, 85Sr,
95Nb, and 46Sc) were agitated in an ultrasonic
mixer for 10 min before injection. A suspension containing 3 × l06 microspheres was injected through the left atrial
catheter while a reference sample of arterial blood was drawn from the
aortic catheter at a rate of 15 ml/min. Radioactivity levels in the
myocardial and blood reference specimens (Cm and
Cr, respectively) were determined using a gamma
spectrometer (Cobra; Packard Instruments; Downers Grove, IL). Knowing
the rate of withdrawal of the reference blood specimen
(
r) and Cr, the Cm was used
to compute
m as:
m =
r (Cm/Cr).
mtATPase subunit protein levels.
Frozen heart samples (weight ~100 mg) were powdered in a liquid
nitrogen-cooled mortar and then added to 1 ml of ice-cold buffer
(containing 0.25 M sucrose, 50 mM Tris · HCl, and 10 mM sodium
azide at pH 8.5). The samples were homogenized and then incubated for
1 h at room temperature. All tissues were centrifuged at 10,000 g for 10 min at room temperature. The supernatants
were used for Western blotting, and protein concentration was
determined by a modified Lowry analysis (protein assay kit; Sigma). The
antibodies 7B3 (against
-subunit F1- ATPase), 19D3
(against
-subunit F1-ATPase), 2B1B1 [against the
oligomycin sensitivity-conferring protein (OSCP) subunit], and 2H10
[against the initiation factor 1 (IF1) subunit] were
produced as described (2, 18). Total protein extract (15 µg) was loaded onto a standard discontinuous 12% SDS polyacrylamide gel run at 200 V for 90 min. Proteins were transferred to
nitrocellulose membranes (Bio-Rad). Transfer efficiency was assessed by
staining the gel with Coomassie blue before and after transfer.
Nonspecific binding sites were blocked by incubating the membrane
overnight in 5% nonfat milk buffer. The primary antibody was diluted
in antibody buffer [1% nonfat milk in 0.1% Tween 20-Tris-buffered saline (TTBS)] and incubated with the membranes for 2 h on a
rotating cylinder. The membrane was washed three times with TTBS buffer for 30 min. Appropriate horseradish peroxidase-labeled secondary antibodies (goat anti-mouse) were then incubated with the membrane for
1 h. The membrane was again washed three times in TTBS buffer before undergoing a 1-min incubation with enhanced chemiluminescent substrate (Amersham). Light emission was detected by exposure to Kodak
RX autoradiography film. Signal densities were quantified by a laser
densitometric scanner (Bio-Rad) and were normalized to the intensities
of the same amount of
-actin protein.
Study protocol.
Ventilation rate, volume, and inspired oxygen content were adjusted to
maintain physiological values for arterial PO2,
PCO2, and pH. Aortic and LV pressures were
monitored continuously throughout the study.
m and
hemodynamic measurements were acquired simultaneously with the
acquisition of 1H and 31P magnetic resonance
spectra. After baseline data were obtained, dobutamine and dopamine (Db
and Dp, respectively) were simultaneously infused (2.5-10
µg · kg
1 · min
1 iv each)
to increase the cardiac work state to a rate pressure product (RPP) of
~20,000
mmHg · beats
1 · min
1. In
failing hearts, if the RPP did not reach 20,000 mmHg/min in response to
catecholamine stimulation, atrial pacing at a rate of 200 beats/min was
then started. A steady state was achieved after ~10 min, and all
measurements were repeated. After completion of this protocol, in four
normal pigs and four animals with LCx ligation (two with CHF), the left
anterior descending artery or the second diagonal branch were
completely occluded, and Mb-
measurements were repeated. The
hearts were then rapidly removed and prepared for blood flow
measurements and tissue sampling.
Tissue preparation. Once the study was completed, a myocardial drill biopsy of the LV wall was taken and frozen in liquid nitrogen for subsequent analysis of ATP and total creatine contents using an HPLC technique (26). The heart was then fixed in 10% buffered formalin. The region of myocardium directly beneath the surface coil was removed and sectioned into three transmural layers from epicardium to endocardium, weighed on an analytic balance, and placed into vials for counting. Similar myocardial specimens were obtained from the lateral and posterior LV walls to ensure that the measurements from the region of myocardium corresponding to the surface coil were typical for the entire left ventricle.
Data analysis. Hemodynamic data were measured from the strip-chart recordings. Transmural blood flow distribution was determined from the microsphere measurements. Data were analyzed with one-way ANOVA for repeated measurements. A value of P < 0.05 was considered significant. When a significant result was found, individual comparisons were made using Scheffé's method.
| |
RESULTS |
|---|
|
|
|---|
Anatomic data.
The anatomic data are summarized in Table
1. In the nine LVR swine, the LV
weight-to-body weight ratio (LVW/BW) was increased by 58% compared
with seven size-matched normal swine (P < 0.05). The
eight CHF swine demonstrated a greater degree of hypertrophy, with the
LVW/BW ratio increased by 86% (P < 0.05). The right
ventricular weight-to-body weight ratio was also increased in hearts
with postinfarction LVR, but only in the hearts with CHF did this
difference reach statistical significance (see Table 1;
P < 0.01).
|
Hemodynamic data.
Hemodynamic data are shown in Table 2.
None of the hemodynamic variables were significantly different between
the normal and LVR groups either at baseline or during the increased
cardiac work state (see Table 2). In contrast, in hearts with CHF, the aortic and LV systolic pressures were significantly lower, and the LV
end-diastolic pressure was significantly higher during the basal state
(see Table 2; P < 0.05). Catecholamine stimulation induced comparable increases of the RPP in the normal and LVR groups
(see Table 2); however, the CHF hearts required a high dose of
catecholamine (Dp and Db, 10 µg · kg
1 · min
1 iv each)
compared with normal animals and pigs with LVR (Dp and Db, 2.5-10
µg · kg
1 · min
1 iv each).
In addition, four of the seven animals with CHF required pacing at 200 beats/min to reach the desired increase in cardiac work state. These
data are consistent with the previous observations that hearts with CHF
have decreased catecholamine responsiveness (31).
|
Myocardial blood flow.
Mean
m measurements were not significantly different
among the three groups of animals under basal conditions, and values increased similarly during the increased cardiac work state (see Table
3). The inner blood flow-to-outer blood
flow ratio (Endo/Epi) tended to be lower in the CHF animals than in the
other two groups, both during basal conditions and during catecholamine
infusion, but this difference did not achieve statistical significance
(see Table 3).
|
Transmural HEP and Pi levels.
Myocardial HEP and Pi data are summarized in Table
4. The voxel-labeled Epi was positioned
over the outer edge of the LV wall, the voxel-labeled Endo was over the
subendocardium (most distant from the coil), and the voxel-labeled Mid
was over the midwall. Spectra obtained at baseline were characterized
by high PCr and ATP levels, whereas Pi was too low to be
detected. At baseline, the PCr-to-ATP (PCR/ATP) ratios were
significantly lower in the subendocardium than in the subepicardium in
both normal hearts and hearts with compensated LVR (see Table 4). Under
basal conditions, the PCr/ATP was significantly lower in Endo than Epi in both normal and LVR hearts, but not in hearts with CHF (see Table
4). During basal conditions, the PCr/ATP was significantly lower than
normal in the Mid and Endo layers of hearts with LVR. The PCr/ATP was
decreased further in animals with CHF, and was significantly lower than
in normal hearts and LVR hearts in all transmural layers during basal
conditions (see Table 4). Catecholamine infusion caused no change in
the PCr/ATP in any transmural layer of normal or LVR hearts. In
contrast, catecholamine infusion caused a further significant decrease
of the PCr/ATP in all transmural layers of hearts with CHF and was
associated with the appearance of a Pi resonance (see Table
4).
|
Biopsy data and myocardial free ADP concentration.
Biopsy data are summarized in Table 5.
ATP levels were significantly lower in both LVR and CHF groups compared
with normal hearts (see Table 5). Myocardial total creatine levels
tended to be lower in both groups of hearts with LVR, but this was
significant only in the hearts with CHF (P < 0.05;
Table 5). Calculated whole wall free ADP levels were significantly
increased in both groups of remodeled hearts, and this was most
prominent in hearts with CHF (see Table 5). Calculated free ADP levels
did not change during catecholamine infusion in normal or LVR hearts.
In contrast, catecholamine infusion caused a significant further
increase of calculated free ADP in hearts with CHF (see Table 5).
|
Myoglobin saturation.
No Mb-
resonance was detected in any heart of any group under basal
conditions or during the increased cardiac work state. During coronary
artery occlusion (which was done as a positive control in four normal
hearts, two hearts with LVR, and two hearts with CHF to verify that the
Mb-
resonance could be detected), a prominent Mb-
resonance
appeared at 71 ppm upfield of the water resonance.
Mitochondrial protein levels of mtATPase subunits.
Western blots of mitochondrial
-F1-ATPase, OSCP, and
IF1 subunits are shown in Figs.
1-3,
respectively. Mean data normalized to
-actin are summarized in Fig.
4. In hearts with compensated LVR,
mtATPase protein subunit expression was not significantly different
from normal (P = not significant; Figs. 1-4).
Compared with normal hearts, in hearts with CHF, mitochondrial
-F1-ATPase was decreased by 36% (P < 0.05),
-F1-ATPase was decreased by 16%
(P < 0.05), OSCP was decreased by 40%
(P < 0.01), and IF1 was decreased by 41%
(P < 0.01).
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The present experimental model of coronary artery occlusion is
characterized by prominent remodeling of the noninfarcted myocardium with dilatation of the LV chamber and elongation and hypertrophy of
individual myocytes (37). Alterations of HEP content and the regulation of myocardial oxidative phosphorylation are also present; these changes are most prominent in animals that develop overt
CHF (20, 37). Despite the presence of significant
remodeling, hearts that remain compensated retain normal responses to
the stress of rapid pacing or catecholamine infusion (20).
Because failing hearts have a blunted response to catecholamines
(20, 31), in the present study, atrial pacing was combined
with catecholamine infusion to produce a modest increase in cardiac
workload with RPPs approaching 20,000 mmHg · beats
1 · min
1. In
normal hearts and hearts with compensated LVR, increases in cardiac
work of this magnitude occurred with no change of HEP levels and
without detectable Pi (see Table 4 ans Refs.
4, 20, 23, 33).
Only when RPPs exceed ~45,000
mmHg · beats
1 · min
1 are
reductions of PCr and accumulation of Pi observed in normal hearts (33). However, in the animals with CHF, even the
modest increase of RPP to ~20,000
mmHg · beats
1 · min
1
achieved in the present study resulted in a further decrease of the
PCr/ATP with the appearance of Pi and an increase in
calculated myocardial free ADP. Although the HEP changes that occurred
during the increased work state in the hearts with CHF were similar to those observed during myocardial ischemia, Mb-
was not
detected. The ability to assess myocardial myoglobin oxygenation allows us to conclude that oxygen insufficiency cannot account for either the
HEP alterations present at baseline or the further perturbation of HEP
levels during the increased cardiac work state in the failing hearts.
In agreement with previous reports (27, 37), myocardial ATP concentrations were decreased in failing hearts in the present study. It is possible that this abnormality is related to the increased ADP levels in the failing hearts. An increase of myocardial free ADP would activate adenylate kinase (myokinase), which catalyzes the transfer of a phosphoryl group between two molecules of ADP to form one molecule each of AMP and ATP (15, 16). AMP can be acted upon by nucleotide phosphorylase to produce adenosine (28). Unlike the nucleotides, adenosine can cross the cell membrane into the interstitial space where it is further degraded to inosine and hypoxanthine to leave the heart through the coronary circulation (13). Even in the normal heart, increases of cardiac work produced by norepinephrine infusion are associated with increases of adenosine released into intracoronary venous blood (9). The greater increases of myocardial ADP levels during catecholamine infusion in the hypertrophied hearts in the present study might be expected to further augment adenosine loss from the heart. Loss of the total adenine nucleotide pool could result in a reduction of ATP, because the de novo resynthesis of adenine nucleotide is a slow and energy-costly process, where inosine monophosphate is produced from ribose-5-phosphate utilizing six HEP bonds (19). For example, the ATP depletion that occurs in postischemic stunned myocardium requires several days for recovery (29, 37). Loss of the adenine nucleotide pool in the failing heart may be facilitated by the persistently normal blood flow levels. In contrast to ischemia, where coronary blood flow is reduced, the normal coronary flow rates in the failing hearts might promote washout of adenosine from the heart.
A central question is whether the observed HEP abnormalities might
contribute to contractile dysfunction in the failing hearts. Although
ATP levels were decreased in the failing hearts, the myocardial ATP
concentrations were nevertheless many times greater than the
Michaelis-Menten (Km) value of either myosin
ATPase or the sarcoplasmic(endo)reticulum calcium ATPase (SERCA)
(7, 14). Furthermore, in postischemic
stunned hearts, ATP levels can be more severely depressed than in the
failing hearts of the present study, but contractile function improves
in response to catecholamine administration, which demonstrates that
the decreased ATP level does not prevent normal contractile performance
(1). Consequently, it is unlikely that the decrease of ATP
in the failing hearts in the present study can account for the
depressed contractile performance. A decrease of the ATP-to-ADP ratio,
as seen in the failing hearts, does result in decreased free energy
released per unit of ATP hydrolysis (
G) (14, 30).
Reductions of
G have the potential to decrease LV contractile
performance but only at values substantially below those calculated in
the failing hearts in the present study (30).
Mitochondrial ATPase.
Mitochondrial ATP synthase embedded in the mitochondrial inner membrane
drives ATP synthesis using energy generated from the electrochemical
proton gradient across the inner mitochondrial membrane
(5). The
- and
-subunits are homologous; both bind nucleotides, but only the
-subunit has catalytic activity. The OSCP
is involved in the efficient binding of F1 to
F0. The ATPase inhibitor protein, IF1, is a
small basic protein that can protect ATP from hydrolysis by the
F1-ATPase. In the present study, the
-,
-, OSCP, and
IF1 subunits were all lower in failing hearts than in
normal hearts, and the decreases were significantly related to the
degree of reduction of the myocardial PCr/ATP, which implies that
reductions of ATPase protein expression were associated with the degree
of increase in ADP levels. A decrease in the
-F1-ATPase activity or an increase in its apparent Km value
with respect to ADP could require an increase in cytosolic ADP and
Pi levels to maintain a given rate of ATP synthesis.
However, because of the presence of endogenous inhibitors including
IF1, ATP synthetic activity cannot be directly equated with
the myocardial F1-ATPase content. Thus Scholz and Balaban
(25) found that incubation of normal myocardium in
high-salt-pH buffer, which is known to promote release of
IF1 from F1-ATPase, caused an increase in
ATPase activity. This demonstrates baseline inhibition and indicates that protein content cannot be directly equated with in vivo enzyme activity. The investigators speculated that the baseline inhibition likely resulted from binding of IF1 (or possibly the
calcium-binding inhibitor protein) (32) to the
F1-ATPase. ATPase activity was not measured in the present
study, but it is likely that the decreased protein expression could
limit the maximum ATP synthesis rates achievable during high work
states in the failing hearts. It is tempting to speculate that the
observed decreases of mitochondrial ATP synthase proteins could
contribute to a compensatory increase of cytosolic ADP levels (and
therefore the decreased PCr/ATP) to maintain ATP synthesis rates in the
failing hearts. However, the present data cannot prove a causal
relationship between the observed decrease of ATPase protein subunits
and the increased levels of ADP and Pi in the failing hearts.
Limitations.
To compensate for the blunted response of the failing hearts to
catecholamine stimulation, rapid pacing was used in four of the seven
failing hearts. It could be argued that in these hearts the increase of
Pi and decrease of the PCr/ATP were caused by ischemia secondary to tachycardia. Thus in hearts with left
ventricular hypertrophy secondary to chronic pressure overload, we
found that pacing-induced tachycardia (without catecholamine infusion)
resulted in a decrease of myocardial HEP levels that was most severe in the subendocardium (34). These HEP changes were
caused by a redistribution of blood flow away from the inner layer of
the LV wall during tachycardia (34). In contrast, in
normal hearts or hearts with eccentric hypertrophy secondary to mitral
regurgitation, pacing caused an increase of blood flow that was uniform
across the LV wall, and myocardial HEP levels remained constant
(35). Furthermore, using the present model of
postinfarction LVR, we previously observed that coronary flow reserve
during maximum vasodilation with adenosine was normal in the failing
hearts (37). Myocardial oxygen consumption was not
measured in the present study because the CHF hearts had difficulty
tolerating the additional surgical manipulation required to insert a
coronary venous catheter. Nevertheless, the normal response of
m to the increased workload in the failing hearts,
as well as the lack of detectable Mb-
, indicates that the HEP
changes observed during the increased workload in the present study
were not caused by ischemia.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grants HL-50470, HL-61353, HL-21872, and HL-33600, and an Established Investigator Award from the American Heart Association (to J. Zhang).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. Zhang, Univ. of Minnesota Health Science Center, Mayo Mail Code 508, 420 Delaware St. SE, Minneapolis, MN 55455 (E-mail: zhang047{at}tc.umn.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 December 2000; accepted in final form 18 April 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ambrosio, G,
Jacobus WE,
Bergman CA,
Weisman HF,
and
Becker LC.
Preserved high-energy phosphate metabolic reserve in globally "stunned" hearts despite reduction of basal ATP content and contractility.
J Mol Cell Cardiol
19:
953-964,
1987[ISI][Medline].
2.
Archinard, P,
Moradi-Ameli M,
Godinot C,
and
Gautheron DC.
Monoclonal antibodies to mitochondrial F1-ATPase and oligomycin-sensitivity conferring protein (OSCP). Tools for recognition of well-conserved and essential antigenic sites.
Biochem Biophys Res Commun
123:
254-261,
1984[ISI][Medline].
3.
Bache, RJ,
Zhang J,
Murakami Y,
Zhang Y,
Cho YK,
Merkle H,
Gong G,
From AHL,
and
U
urbil K.
Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy.
Cardiovasc Res
42:
616-626,
1999
4.
Balaban, RS,
Kantor HL,
Katz LA,
and
Briggs RW.
Relation between work and phosphate metabolites in the in vivo paced mammalian heart.
Science
232:
1121-1123,
1986
5.
Boyer, PD.
The ATP synthase
a splendid molecular machine.
Annu Rev Biochem
66:
717-749,
1997[ISI][Medline].
6.
Chen, W,
Zhang J,
Eljgelshoven MHJ,
Zhang Y,
Zhu X-H,
Wang C,
Cho Y,
Merkle H,
and
U
urbil K.
Determination of deoxymyoglobin changes during graded myocardial ischemia: an in vivo 1H NMR spectroscopy study.
Magn Reson Med
38:
193-197,
1997[ISI][Medline].
7.
Davies, CH,
Harding SE,
and
Poole-Wilson PA.
Cellular mechanisms of contractile dysfunction in human heart failure.
Eur Heart J
17:
189-198,
1996
8.
De Sousa, E,
Veksler V,
Minajeva A,
Kaasik A,
Mateo P,
Mayoux E,
Hoerter J,
Bigard X,
Serrurier B,
and
Ventura-Clapier R.
Subcellular creatine kinase alterations. Implications in heart failure.
Circ Res
85:
68-76,
1999
9.
Gorman, MW,
Ning XH,
He MX,
Portman MA,
and
Sparks HV.
Adenosine release and high-energy phosphates in intact dog hearts during norepinephrine infusion.
Circ Res
70:
1146-1151,
1992
10.
Haase, A,
Frahm J,
Hanicke W,
and
Matthaei D.
1H NMR chemical shift selective (CHESS) imaging.
Phys Med Biol
30:
341-344,
1985[ISI][Medline].
11.
Hendrich, K,
Merkle H,
Weisdorf S,
Vine W,
Garwood M,
and
U
urbil K.
Phase modulated rotating frame spectroscopic localization using an adiabatic plane rotation pulse and a single surface coil.
J Magn Reson
92:
258-275,
1991[ISI].
12.
Hoang, CD,
Zhang J,
Payne RM,
and
Apple FS.
Post-infarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium.
Am J Pathol
151:
257-264,
1997[Abstract].
13.
Imai, S,
Riley AL,
and
Berne RM.
Effect of ischemia on adenine nucleotides in cardiac and skeletal muscle.
Circ Res
15:
443-450,
1964
14.
Ingwall, JS.
Is cardiac failure a consequence of decreased energy reserve?
Circulation
87, SupplVII:
58-62,
1993[ISI].
15.
Iyengar, MR.
Creatine kinase as an intracellular regulator.
J Muscle Res Cell Motil
5:
527-534,
1984[ISI][Medline].
16.
Kroll, K,
Kinzie DJ,
and
Gustafson LA.
Open-system kinetics of myocardial phosphoenergetics during coronary underperfusion.
Am J Physiol Heart Circ Physiol
272:
H2563-H2576,
1997
17.
Lawson, JWR,
and
Veech RL.
Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.
J Biol Chem
254:
6528-6537,
1979
18.
Lopez-Mediavilla, C,
Vigny H,
and
Godinot C.
Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase
-subunit.
Eur J Biochem
215:
487-496,
1993[ISI][Medline].
19.
Manfredi, JP,
and
Holmes EW.
Purine salvage pathways in myocardium.
Annu Rev Physiol
47:
691-705,
1985[ISI][Medline].
20.
Murakami, Y,
Zhang Y,
Cho YK,
Mansoor AM,
Chung JK,
Chu C,
Francis G,
U
urbil K,
Bache RJ,
From AHL,
Jerosch-Herold M,
Wilke N,
and
Zhang J.
Myocardial oxygenation during high workstates in hearts with post-infarction remodeling.
Circulation
99:
942-948,
1999
21.
Neubauer, S,
Horn M,
Cramer M,
Harre K,
Newell JB,
Peters W,
Pabst T,
Ertl G,
Hahn D,
Ingwall JS,
and
Kochsiek K.
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
Circulation
96:
2190-2196,
1997
22.
Ning, X-H,
Zhang J,
Liu J,
Ye Y,
Chen S-H,
From AHL,
Bache RJ,
and
Portman MA.
Signaling and expression for mitochondrial membrane proteins during left ventricular remodeling and contractile failure after myocardial infarction.
J Am Coll Cardiol
36:
282-287,
2000
23.
Portman, MA,
Heineman FW,
and
Balaban RS.
Developmental changes in the relation between phosphate metabolites and oxygen consumption in the sheep heart in vivo.
J Clin Invest
83:
456-464,
1989.
24.
Robitaille, PM,
Merkle H,
Sublett E,
Hendrich K,
Lew B,
Path G,
From AHL,
Bache RJ,
and
U
urbil K.
Spectroscopic imaging and spatial localization using adiabatic pulses and applications to detect transmural metabolite distribution in the canine heart.
Magn Reson Med
10:
14-37,
1989[ISI][Medline].
25.
Scholz, TD,
and
Balaban RS.
Mitochondrial F1-ATPase activity of canine myocardium: effects of hypoxia and stimulation.
Am J Physiol Heart Circ Physiol
266:
H2396-H2403,
1994
26.
Sellevold, OF,
Jynge P,
and
Aarstad K.
High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenosine nucleotides in myocardial tissue.
J Mol Cell Cardiol
18:
517-527,
1986[ISI][Medline].
27.
Shen, W,
Asai K,
Uechi M,
Mathier MA,
Shannon RP,
Vatner SF,
and
Ingwall JS.
Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs.
Circulation
100:
2113-2128,
1999
28.
Skladanowski, AC,
and
Newby AC.
Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.
Biochem J
268:
117-122,
1990[ISI][Medline].
29.
Swain, JL,
Sabina RL,
McHale PA,
Greenfield JC, Jr,
and
Holmes EW.
Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog.
Am J Physiol Heart Circ Physiol
242:
H818-H826,
1982.
30.
Tian, R,
and
Ingwall JS.
Energetic basis for reduced contractile reserve in isolated rat hearts.
Am J Physiol Heart Circ Physiol
270:
H1207-H1216,
1996
31.
Van Woerkens, LJ,
Van Der Giessen WJ,
and
Verdouw PD.
Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure.
Crit Care Med
21:
420-424,
1993[ISI][Medline].
32.
Yamada, EW,
and
Huzel NJ.
Calcium-binding ATPase inhibitor protein of bovine heart mitochondria. Role in ATP synthesis and effect of Ca2+.
Biochemistry
28:
9714-9718,
1989[Medline].
33.
Zhang, J,
Duncker DJ,
Xu Y,
Zhang Y,
Path G,
Merkle H,
Hendrick K,
From AHL,
Bache RJ,
and
U
urbil K.
Transmural bioenergetic responses of normal myocardium to high workstates.
Am J Physiol Heart Circ Physiol
268:
H1891-H1905,
1995
34.
Zhang, J,
Merkle H,
From AHL,
U
urbil K,
and
Bache RJ.
Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
J Clin Invest
92:
993-1003,
1993.
35.
Zhang, J,
Toher C,
Erhard M,
Zhang Y,
U
urbil K,
Bache RJ,
Lange T,
and
Homans DC.
Bioenergetic and functional consequences of left ventricular volume overload hypertrophy.
Circulation
96:
334-343,
1997
36.
Zhang, J,
U
urbil K,
From AHL,
and
Bache RJ.
High-energy phosphate metabolism in normal and abnormal myocardium: evaluation with in vivo magnetic resonance spectroscopy.
J Cardiovasc Magn Reson
2:
23-32,
2000[ISI][Medline].
37.
Zhang, J,
Wilke N,
Wang Y,
Zhang Y,
Wang C,
Eijgelshoven MHJ,
Cho YK,
Murakami Y,
U
urbil K,
Bache RJ,
and
From AHL
Functional and bioenergetic consequences of post-infarction left ventricular remodeling in a new porcine model: an MRI and 31P-MRS study.
Circulation
94:
1089-1100,
1996
This article has been cited by other articles:
![]() |
M. van Bilsen, F. A. van Nieuwenhoven, and G. J. van der Vusse Metabolic remodelling of the failing heart: beneficial or detrimental? Cardiovasc Res, November 6, 2008; (2008) cvn282v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Rosca, E. J. Vazquez, J. Kerner, W. Parland, M. P. Chandler, W. Stanley, H. N. Sabbah, and C. L. Hoppel Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation Cardiovasc Res, October 1, 2008; 80(1): 30 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Eisen Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1892 - 1895. [Full Text] [PDF] |
||||
![]() |
J. Feygin, Q. Hu, C. Swingen, and J. Zhang Relationships between regional myocardial wall stress and bioenergetics in hearts with left ventricular hypertrophy Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2313 - H2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Feygin, A. Mansoor, P. Eckman, C. Swingen, and J. Zhang Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1772 - H1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zeng, Q. Hu, X. Wang, A. Mansoor, J. Lee, J. Feygin, G. Zhang, P. Suntharalingam, S. Boozer, A. Mhashilkar, et al. Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling Circulation, April 10, 2007; 115(14): 1866 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neubauer The Failing Heart -- An Engine Out of Fuel N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151. [Full Text] [PDF] |
||||
![]() |
Q. Hu, X. Wang, J. Lee, A. Mansoor, J. Liu, L. Zeng, C. Swingen, G. Zhang, J. Feygin, K. Ochiai, et al. Profound bioenergetic abnormalities in peri-infarct myocardial regions Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H648 - H657. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wallis, C. A. Lygate, A. Fischer, M. ten Hove, J. E. Schneider, L. Sebag-Montefiore, D. Dawson, K. Hulbert, W. Zhang, M. H. Zhang, et al. Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure: Insights From Creatine Transporter-Overexpressing Transgenic Mice Circulation, November 15, 2005; 112(20): 3131 - 3139. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Regula, M. J. Rzeszutek, D. Baetz, C. Seneviratne, and L. A. Kirshenbaum Therapeutic opportunities for cell cycle re-entry and cardiac regeneration Cardiovasc Res, December 1, 2004; 64(3): 395 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Gourine, Q. Hu, P. R. Sander, A. I. Kuzmin, N. Hanafy, S. A. Davydova, D. V. Zaretsky, and J. Zhang Interstitial purine metabolites in hearts with LV remodeling Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H677 - H684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Czubryt and E. N. Olson Balancing Contractility and Energy Production: The Role of Myocyte Enhancer Factor 2 (MEF2) in Cardiac Hypertrophy Recent Prog. Horm. Res., January 1, 2004; 59(1): 105 - 124. [Abstract] [Full Text] |
||||
![]() |
G. Gong, J. Liu, P. Liang, T. Guo, Q. Hu, K. Ochiai, M. Hou, Y. Ye, X. Wu, A. Mansoor, et al. Oxidative capacity in failing hearts Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H541 - H548. [Abstract] [Full Text] [PDF] |